SCYNEXIS, Inc.
SCYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | -0.04 | 0.26 | -0.02 |
| FCF Yield | -22.71% | -22.33% | -15.86% | -21.56% |
| EV / EBITDA | -138.87 | 9.32 | 12.56 | -12.36 |
| Quality | ||||
| ROIC | -19.52% | -19.02% | -14.50% | -9.99% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 1.02 | 1.09 | 1.38 | 2.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -72.16% | -71.15% | -21.96% | -9.72% |
| Free Cash Flow Growth | -16.40% | -0.40% | 24.65% | -1,395.03% |
| Safety | ||||
| Net Debt / EBITDA | 67.70 | -3.23 | -1.31 | -0.06 |
| Interest Coverage | 0.00 | 0.00 | -17.75 | -11.93 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 2,694.61 | 659.82 | 3,405.64 | 945.32 |